Virbac, one of the world’s leading companies in animal health, is continuing its expansion in Europe.
In addition to the recent finalization of the creation of its Irish subsidiary, Virbac announces the acquisition of its historical distributor in the Czech Republic and Slovakia, which becomes its 35th subsidiary.
This development strategy strengthens the group’s position in the European market for animal health.
Present in the Czech Republic and Slovakia since 2000 through its historical distributor, Virbac is well aware of these two markets, mainly oriented towards pets and ruminants.
In order to continue the development of its activities in this region and strengthen its presence in Central Europe, Virbac has acquired GS Partners, one of its oldest distributors in this area. This acquisition crowns the excellent work done for years by the teams of Jakub Satrapa, its former owner and future CEO of the Virbac subsidiary.
The new Virbac subsidiary in Ireland and the acquisition of GS Partners in the Czech Republic and Slovakia will allow the group to respond more broadly and quickly to the health needs of animals in these countries. Therefore, this development strategy strengthens Virbac’s position in the European animal health market, where the group continues to grow and expand.
Healthtech & Biotech News – Nice Côte d’Azur France
- Horus Pharma accelerates its international expansion across 8 new countries
- Health Afterwork in Nice: connecting innovators in the HealthTech sector
- Team Nice Côte d’Azur at Bio International Convention 2025 : Smart Pipelines and Global Partnerships
- Université Côte d’Azur to open a pharmacy department
- Team Nice Côte d’Azur at Viva Technology 2025: boosting attractiveness through sustainable innovation
- Business Landing Nice Côte d’Azur: Support for business set up in France
- Bpifrance in Provence–Alpes–Côte d’Azur: 6,432 businesses supported in 2024
- “Unlocking Life Sciences Opportunities in the South of France”, a Success for the Life Sciences Investment in Nice!
- Strategic sector start-up acceleration program: health, blue economy, and cultural and creative industries.
- Life sciences: the strategic advantage of the Nice Côte d’Azur region
